Unknown

Dataset Information

0

Risk of colon cancer recurrence in relation to diabetes.


ABSTRACT: PURPOSE:To describe the association between diabetes and colon cancer recurrence. METHODS:We conducted a cohort study at two integrated health care delivery systems in the United States. Using tumor registry data, we identified patients aged ??18 years when diagnosed with stage I-IIIA adenocarcinomas of the colon during 1995-2014. Pre-existing diabetes was ascertained via diagnosis codes. Medical records were reviewed for eligibility and to abstract recurrence and covariate information. Recurrence was ascertained beginning 90 days after the end of colon cancer treatment (i.e., cohort entry). Recurrence of any cancer or a new primary cancer at any site was a secondary outcome. We used multivariable Cox proportional hazards models to estimate hazard ratios (HR) and 95% confidence intervals (CIs) for the associations between diabetes at cohort entry and study outcomes. RESULTS:Among the 1,923 eligible patients, 393 (16.7%) had diabetes at cohort entry. Diabetes was not associated with recurrence (HR 0.87; 95% CI 0.56-1.33) or with any subsequent cancer (HR 1.09; 95% CI 0.85-1.40). When the definition of recurrence included second primary colorectal cancer, risk was non-significantly higher in patients with diabetes than without diabetes. CONCLUSIONS:The risk of colon cancer recurrence appears to be similar in patients with and without diabetes at diagnosis. IMPACT:Future studies should evaluate the association between diabetes and colorectal cancer outcomes, especially second primary colon cancers, in larger populations.

SUBMITTER: Chubak J 

PROVIDER: S-EPMC6230488 | biostudies-literature | 2018 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications


<h4>Purpose</h4>To describe the association between diabetes and colon cancer recurrence.<h4>Methods</h4>We conducted a cohort study at two integrated health care delivery systems in the United States. Using tumor registry data, we identified patients aged ≥ 18 years when diagnosed with stage I-IIIA adenocarcinomas of the colon during 1995-2014. Pre-existing diabetes was ascertained via diagnosis codes. Medical records were reviewed for eligibility and to abstract recurrence and covariate inform  ...[more]

Similar Datasets

| S-EPMC7669228 | biostudies-literature
| S-EPMC6170705 | biostudies-literature
| S-EPMC6076224 | biostudies-literature
| S-EPMC8733234 | biostudies-literature
| S-EPMC4913547 | biostudies-literature
2018-08-01 | GSE97781 | GEO
| S-EPMC3741453 | biostudies-literature
| S-EPMC5670360 | biostudies-literature
| S-EPMC8189445 | biostudies-literature
| S-EPMC3229275 | biostudies-literature